Summary
Studies were performed to evaluate the relative importance of enhanced adipose tissue lipolysis and increased insulin levels in modulating hepatic VLDL production in patients with endogenous hypertriglyceridaemia. Eight control subjects and nine patients with hypertriglyceridaemia were investigated. The latter group comprised four patients with idiopathic hypertriglyceridaemia, three maturity onset diabetics, and two siblings with diabetic lipodystrophy. Each individual's plasma VLDL was selectively labelled with I131 in the apoprotein moiety and then reinjected to assess the turnover of these molecules. This was correlated with the insulin response to an oral glucose load and with the plasma FFA flux measured by a continuous infusion of14C palmitate. In the patients with idiopathic hypertriglyceridaemia and in the adult onset diabetics, plasma VLDL-apoprotein turnover was increased suggesting enhanced hepatic production of these molecules. Although the insulin levels in these patients were higher than normal, no significant correlation was demonstrable between the plasma insulin and the turnover of VLDL-B-apoprotein. Furthermore, in the two patients with lipo-dystrophy the turnover of plasma VLDL was within the normal range, whereas the plasma insulin responses were the highest among all the patients. These results suggest that hyperinsulinaemia alone is not sufficient to account for the increased VLDL production seen in some of our patients. The plasma FFA flux was raised in the patients with idiopathic hypertriglyceridaemia and in the maturity onset diabetics, and was within the normal range in the two patients with lipodystrophy. Indeed, in all the subjects studied a significant correlation was observed between the turnover of plasma VLDL-B-apoprotein and the plasma FFA flux. The results thus indicate that the rate of FFA release to plasma constitutes the predominant factor in determining hepatic output of VLDL and that in the majority of patients with endogenous hypertriglyceridaemia the increased FFA flux resulting from insulin resistance in adipose tissue could effectively increase VLDL production. This process appears to be independent of the prevailing insulin levels, and could occur in the presence of insulin resistance in the liver. The latter, however, could be responsible for the impaired glucose tolerance observed in some patients.
Article PDF
Similar content being viewed by others
References
Farquhar, J. W., Frank, A., Gross, R. C., Reaven, G. M.: Glucose, insulin and triglyceride responses to high and low carbohydrate diets in man. J. clin. Invest.45, 1648–1656 (1966)
Reaven, G. M., Lerner, R. L., Stern, M. P., John, W., Nakaknishi, R.: Role of insulin in endogenous hypertriglyceridemia. J. clin. Invest.46, 1756–1767 (1967)
Olefsky, J. M., Farquhar, J. W., Reaven, G. M.: Reappraisal of the role of insulin in hypertriglyceridemia. Amer. J. Med.57, 551–560 (1974)
Havel, R.: Lipid transport and insulin resistance. Excerpta med. (Amst.)20, 353–359 (1973)
Bray, G. A., Yorks, D. A.: Genetically transmitted obesity in rodents. Physiol. Rev.51, 598–676 (1971)
Kahn, C. R., Neville, D. M., Jr., Roth, J.: Insulin-receptor interaction in the obese-hyperglycaemic mouse. J. biol. Chem.248, 244–251 (1973)
Adams, P. W., Kissebah, A. H., Harrigan, P., Stokes, T., Wynn, V.: The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism. Europ. J. clin. Invest.4, 149–161 (1974)
Kissebah, A. H., Alfarsi, S., Adams, P. W., Seed, M., Folkard, J., Wynn, V.: Transport kinetics of plasma free fatty acids, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: Effects of 2, 2-Dimethyl, 5 (2, 5-xylyoxy) valeric acid therapy. Atherosclerosis24, 199–218 (1976)
Barter, P. J., Nestel, P. J., Carroll, K. F.: Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration and alcoholic fatty liver. Metabolism21, 117–124 (1972)
Barter, P. J., Nestel, P. J.: Precursors of plasma triglyceride fatty acids in obesity. Metabolism22, 779–785 (1973)
Hatch, F. T., Lees, R. S.: Practical methods for plasma lipoprotein analysis. In: Advances in lipid research, 6 (eds. R. Paoletti, D. Kritchevsky), p. 16. New York-London: Academic Press 1968
MacFarlane, A. S.: Efficient trace-labelling of proteins with iodine. Nature (Lond.)182, 53 (1968)
Stern, H. S., McAfee, J. G., Follie, I.: Paper chromatography of iodinated proteins. In: Radioactive Pharmaceuticals, Chapt. 19 (eds. G. A. Andres, R. M. Kinsley, H. N. Wagner), p. 359. U. S. Atomic Energy Commission 1966
Eisenberg, S., Rachmilewitz, D., Stein, O., Stein, Y.: Metabolic non-homogeneity of lecithin and cholesterol in aortae. Biochim. biophys. Acta. (Amst.)231, 198–207 (1971)
Kane, J. P.: A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins. Analyt. Biochem.53, 350–356 (1973)
Bilheimer, D. W., Eisenberg, S., Levy, R. I.: The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. biophys. Acta (Amst.)260, 212–221 (1972)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with folinphenol reagent. J. biol. Chem.193, 265–275 (1951)
Kissebah, A. H., Adams, P. W., Wynn, V.: Plasma free fatty acid and triglyceride transport kinetics in man. Clin. Sci. and Mol. Med.47, 259–278 (1974)
Trout, D. L., Estes, E. H., Friedberg, S. J.: Titration of free fatty acid of plasma. A study of current methods and a new modification. J. Lipid Res.1, 199–202 (1960)
Cramp, D. G.: New automated method for measuring glucose by glucose oxidase. J. clin. Path.20, 910–912 (1967)
Albano, J. D., Ekins, R. P., Maritz, G., Turner, R. C.: A sensitive precise radio-immuno assay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta endocr. (Kbh.).70, 487–509 (1972)
Wynn, V., Doar, J. W.: Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966II, 715–720
Cramp, D. G., Robertson, G. R.: The fluorimetric assay of triglyceride by a semi-automated method. Analyt. Biochem.25, 246–251 (1968)
Robertson, G. R., Cramp, D. G.: An evaluation of cholesterol determination in serum and serum lipoprotein fractions by a semiautomated fluorimetric method. J. clin. Path.23, 243–251 (1970)
Nikkila, E. A., Kekki, M.: Polymorphism of plasma triglyceride kinetics in normal human adult subjects. Acta med. scand.190, 49–59 (1971)
Eaton, R. P., Steinberg, D., Berman, M.: Quantitative evaluation of free fatty acid and triglyceride fatty acid metabolism in man. J. clin. Invest.44, 1041 (1965)
Salans, L. B., Reaven, G. M.: Effects of insulin pretreatment on glucose and lipid metabolism of liver slices from normal rats. Proc. Soc. exp. Biol. (N. Y.)122, 1208–1213 (1966)
Letarte, J., Fraser, T. R.: Stimulation by insulin of the incorporation of U14 C-glucose into lipids released by the liver. Diabetologia5, 358–364 (1969)
Haft, D. E.: Effects of insulin on glucose metabolism by the perfused normal rat liver. Amer. J. Physiol.213, 219–230 (1967)
Schlierf, G., Kinsell, L. W.: Effect of insulin in hypertri glyceridaemia. Proc. Soc. exp. Biol. (N. Y.)120, 272–278 (1965)
Havel, R. J., Kane, J. P., Balasse, E. O., Segal, N., Basso, L. V.: Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridaemic and hypertriglyceridamic humans. J. clin. Invest.49, 2017–2035 (1970)
Boberg, J., Carlson, L. A., Freyschuss, U.: Determination of splanchnic secretion rate of plasma triglycerides and of total and splanchnic turnover of plasma free fatty acids in man. Europ. J. clin. Invest.2, 123–132 (1972)
Schlierf, G., Dorow, E.: Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate induction in man and their modification by nocturnal suppression of lipolysis. J. clin. Invest.52, 732–739 (1973)
Schlierf, G., Reinheimer, W., Strassberg, V.: Diurnal patterns of plasma triglycerides and free fatty acids in normal subjects and in patients with endogenous (type IV) hyperlipo proteinaemia. Nutr. Metab.13, 80–92 (1971)
Nikkila, E. A., Kekki, M.: Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism22, 1–22 (1973)
Larsson, B., Bjöntorp, P., Holm, J., Scherstein, T., Sjöström, L., Smith, U.: Adipocyte metabolism in endogenous hypertri glyceridaemia. Metabolism24, 1375–1389 (1975)
Björntorp, P., Krotbrewski, M., Larsson, B.: Effects of feeding states on lipid radioacitivity in liver, muscle and adipose tissue after injection of labelled glucose in the rat. Acta. physiol. scand.80, 29–38 (1970)
Sjöström, L.: Adult human adipose tissue cellularity and metabolism. Acta med. scand. Suppl.544, 1–53 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kissebah, A.H., Alfarsi, S., Adams, P.W. et al. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12, 563–571 (1976). https://doi.org/10.1007/BF01220632
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01220632